(REGN) |
| 0 (0%) 09-02 23:40 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 998.04 |
| Resistance 1: | 854.49 |
| Pivot price: | 818.53 |
| Support 1: | 755.41 |
| Support 2: | 694.17 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 40.450 |
| Book Value | 316.110 |
| PEG Ratio | 1.39 |
| Gross Profit | 68.321 |
| Profit Margin (%) | 27.86 |
| Operating Margin (%) | 33.11 |
| Return on Assets (ttm) | 6.5 |
| Return on Equity (ttm) | 14.0 |
Company news
Wed, 02 Sep 2026
REGN Deadline Alert: Levi & Korsinsky Reminds Regeneron Pharmaceuticals (REGN) Investors of Securities Class Action Deadline on September 14, 2026 - PR Newswire
Wed, 02 Sep 2026
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Mon, 31 Aug 2026
Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)? - simplywall.st
Mon, 31 Aug 2026
REGN Shareholder Alert: Regeneron Pharmaceuticals, Inc. - GlobeNewswire
Mon, 31 Aug 2026
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Sun, 30 Aug 2026
REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - natlawreview.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
